Terns Pharmaceuticals, Inc. (TERN) Retained Earnings (Accumulated Deficit) USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Terns Pharmaceuticals, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2020 to 2024.
  • Terns Pharmaceuticals, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$355 M, a 34.5% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$355 M -$91.1 M -34.5% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$333 M -$90.2 M -37.2% Dec 31, 2023 10-Q 2024-05-13
Q3 2023 -$312 M -$85 M -37.5% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$282 M -$72.1 M -34.4% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 -$264 M -$68.1 M -34.8% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$242 M -$60.3 M -33.1% Dec 31, 2022 10-K 2024-03-14
Q3 2022 -$227 M -$58.8 M -35% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 -$210 M -$53.8 M -34.5% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 -$196 M -$50.6 M -34.8% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 -$182 M -$50.2 M -38% Dec 31, 2021 10-K 2023-03-27
Q3 2021 -$168 M Sep 30, 2021 10-Q 2021-11-15
Q2 2021 -$156 M Jun 30, 2021 10-Q 2021-08-16
Q1 2021 -$145 M Mar 31, 2021 10-Q 2021-05-14
Q4 2020 -$132 M Dec 31, 2020 10-K 2022-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.